UnknownNot applicableNCT01786889
Identification, Molecular Epidemiology Angiosarcoma of the Liver France
Studying Angiosarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Oscar Lambret
- Principal Investigator
- LE MOAL Joelle, Dr, MDInstitut de Veille Sanitaire_Département Santé Environnement
- Intervention
- blood and urine(biological)
- Enrollment
- 9 enrolled
- Eligibility
- All sexes
- Timeline
- 2013 – 2017
Study locations (12)
- Institut Bergonié, Bordeaux, France
- Centre Jean Perrin, Clermont-Ferrand, France
- Centre Georges François, Dijon, France
- Centre Oscar Lambret, Lille, France
- Centre Léon Bérard, Lyon, France
- Hôpital de la TIMONE, Marseille, France
- CRLCC Montpellier, Montpellier, France
- Hopital Tenon, Paris, France
- Institut de Cancérologie Lucien, Saint-Priest-en-Jarez, France
- CHU Strasbourg, Strasbourg, France
- Institut Claudius Regaud, Toulouse, France
- Chu / Hopital Trousseau, Tours, France
Collaborators
Institut de Veille Sanitaire
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01786889 on ClinicalTrials.govOther trials for Angiosarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06898970Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for AngiosarcomaVarun Monga, MBBS
- RECRUITINGPHASE2NCT07007273Pembrolizumab for Advanced Cutaneous Sarcomas Not Including AngiosarcomaH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNCT06715579Cardiac Angiosarcoma International RegistryImmune Oncology Research Institute
- RECRUITINGPHASE2NCT06849986IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)Fudan University
- RECRUITINGPHASE2NCT06673628Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma PatientsNational Cancer Center, Japan
- RECRUITINGPHASE1NCT06440005A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsAngiex, Inc.
- RECRUITINGNCT06375941Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStarsItalian Sarcoma Group
- RECRUITINGNCT06541652A French Multicenter Observational Retrospective Study of Rare Primary Liver CancersFederation Francophone de Cancerologie Digestive